Metech International Limited FY2025 Financial Results: Recovery in Revenue but Ongoing Challenges

Metech International Limited released its unaudited financial statements for the fourth quarter and full year ended 31 December 2025. The company operates in the health supplements, lab-grown diamonds, and food waste processing sectors. Below, we present a detailed analysis of Metech’s financial and operational performance, trends, exceptional items, and corporate actions, with actionable recommendations for investors.

Key Financial Metrics and Performance Table

*Q3 values are derived from first six months minus Q4 results, as reported in the breakdown of sales.
n.m. = not meaningful due to shift from loss to profit.

Historical Performance Trends

• Revenue: FY2025 revenue rose 48.1% YoY to S\$4.34 million, driven by the new health supplements business. However, Q4FY2025 revenue declined 55.6% YoY and 58.1% QoQ due to supplier licensing delays and a change in supplier.
• Gross Profit Margin: Improved from 5.25% in FY2024 to 12.41% in FY2025, reflecting economies of scale as the health supplement segment scaled up.
• Net Loss: Full-year net loss narrowed to S\$469,000 (FY2024: S\$2.62 million), aided by higher revenue and lower administrative and impairment expenses.
• EPS: Loss per share improved from -1.52 Singapore cents to -0.26 cents YoY; Q4FY2025 showed a positive EPS of 0.11 cents (vs -0.83 cents in Q4FY2024).

Exceptional Items and One-Offs

• Impairment Losses: In FY2024, S\$775,000 impairment loss on property, plant, and equipment was recorded. No such impairment in FY2025.
• Gains on Disposal: The Group booked S\$239,000 gain from disposal of property, plant, and equipment in FY2025, contributing to other income.

Asset and Liability Developments

• Cash Position: Cash and bank balances fell from S\$1.47 million (end FY2024) to S\$198,000 (end FY2025), mainly due to increased trade receivables and working capital requirements.
• Trade and Other Receivables: Increased to S\$2.26 million (from S\$179,000), largely due to the health supplements business and deposits for new office premises.
• Disposal Group Assets: Asian Eco Technology Pte. Ltd. (AET), the Group’s lab-grown diamond arm (80% held), is classified as held for sale pending a disposal to Wuhan Xilu Trading Co., Ltd.
• Loan from Employee: S\$3 million interest-free loan from Mr. Cao Shixuan (controlling shareholder) remains available for drawdown, with discussions on partial conversion to equity and extension ongoing.
• Negative Net Assets: The Group’s net liability value per share improved but remained negative at -0.20 cents (from -0.40 cents), reflecting its ongoing restructuring and losses.

Corporate Actions, Fundraising, and Related-Party Transactions

• Share Placement: S\$800,000 in new shares issued in FY2025 to strengthen capital base.
• No Dividends: No dividend declared for FY2025 as the Group focuses on expansion and restructuring.
• Related-Party Loan: The S\$3 million loan from Mr. Cao, the controlling shareholder, is a key source of liquidity, with plans for partial debt-to-equity conversion under negotiation.
• Divestment: AET (lab-grown diamond business) is being divested, reflecting the Group’s strategic shift away from this underperforming sector.

Segmental Review and Business Outlook

• Health Supplements: Now the main revenue driver, with expansion in China. Supplier licensing delays affected Q4 sales, but efforts are underway to boost production and sales.
• Food Waste Business: Testing and commissioning of biomass carbon reduction machines was completed. Initial commercial tests with partners are planned, reflecting potential for new revenue streams.
• Lab-Grown Diamonds: Weak performance and ongoing global uncertainties led to the divestment decision. The business contributed negligible revenue in FY2025.

Chairman’s Statement and Tone

The company’s CEO, Pang Wei Hao, outlined a cautiously optimistic outlook, stating that the company is “actively working to grow its health supplement sales by leveraging the health supplements license recently obtained by its supplier to expand marketing efforts and sales outreach across various regions of the People’s Republic of China.” The report also highlights plans for collaboration and restructuring, with the tone focused on prudent optimism and safeguarding long-term growth and shareholder value.

Risk Factors, Exceptional Events, and Going Concern

• Going Concern: Auditors previously expressed uncertainty, but management believes the company remains a going concern, citing ongoing fundraising, potential asset monetization, and continued support from the controlling shareholder.
• Working Capital: Despite a negative working capital of S\$1.43 million, management expects sufficient cash flow via projections, planned fundraising, and asset sales.
• Legal/Other Events: No major litigation or disasters reported. However, the Group is exposed to macroeconomic shifts, supplier licensing delays, and changes in working capital needs.

Conclusion and Investment Recommendations

Overall, Metech International Limited’s FY2025 results show a significant recovery in revenue and narrowing losses, thanks to the health supplements business. However, the company still faces negative net assets, ongoing cash burn, and a need for further restructuring, including divestment of the underperforming diamond segment.

• If you currently hold shares:
  • Maintain a cautious stance. While short-term profitability has improved and the health supplements business provides growth prospects, ongoing negative working capital and dependence on related-party financing remain risks. Consider reducing exposure if liquidity is a concern, but holding may be justified if you believe in management’s turnaround and the prospects of the supplements and food waste businesses.
• If you do not hold shares:
  • Wait and monitor. The company is still working through restructuring and cash flow challenges. Entry may become attractive if further evidence of sustained profitability, improved working capital, and successful divestment/fundraising emerges. For now, the risk/reward profile is weighted to the downside for new investors.

Disclaimer: This analysis is based strictly on the company’s published financial reports and does not constitute investment advice. Investors should conduct their own due diligence and consider their risk appetite before making any investment decisions.

View Metech Intl Historical chart here